Ombowstring , if they doing their job right knowing that MDR patients with HIV dying daily , about 700,000 patients globally every year ,
they will approve today 350 mg dose of Leronlimab with 81% efficacy, and no serious side effects , and play with higher dose next .
The drugs they have now , is Maraviroc with 45% efficacy and severe side effects..
And Ibalizumab with 43% efficacy , IV treatment and also some side effects..
So yes , I hope they will do their job right , save life's , approve 350 mg with 81% efficacy for now , and then play with 700 mg..
People dying every day...
And all IMO.
Market Data 
Markets 
AI
